CLNN — Clene Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1822791 ·
Last close
$3.22
Market Cap
$46.37M
52W High
$10.84
52W Low
$3.02
ADV30
96,432
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 56,000 40,000 -6,105,000 3,915,000 22,157,000 9,887,000 36,965,000
Jun 2026 90,000 54,000 -5,164,000 -13,424,000 23,041,000 9,671,000 47,818,000
Mar 2026 15,000 15,000 -1,692,000 -8,091,000 21,665,000 5,939,000 40,471,000
Dec 2025 77,000 54,000 -7,244,000 -9,226,000 18,131,000 5,189,000 35,723,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-16,532,000
Investing CF
$-90,000
Financing CF
$18,498,000
CapEx
$-79,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.57
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-325,896,000
Inventory
$41,000
Receivables
$1,408,000
ST Investments
—
EBIT TTM
$-23,929,000
Pretax Income TTM
$-26,826,000
Interest Exp TTM
$2,897,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$197,000
EBITDA
$-19,118,000
Free Cash Flow
$-9,874,000
Enterprise Value
$65,351,904
Total Cash
$9,671,000
Total Debt
$22,344,000
Shares Out
14,400,175
Trailing EPS
$-2.30
Book Value
$-1.62
ROE
—
ROA
-56.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 200,000 -21,816,000 -26,173,000 18,131,000 35,723,000 -17,592,000 -18,546,000
Dec 2024 342,000 -31,975,000 -39,400,000 27,337,000 36,194,000 -8,857,000 -21,326,000
Dec 2023 654,000 -38,260,000 -49,504,000 52,341,000 38,951,000 13,390,000 -30,171,000
Dec 2022 473,000 -44,557,000 -29,918,000 44,493,000 41,256,000 3,237,000 -39,011,000

TTM Snapshot

Revenues TTM
$197,000
NetIncome TTM
$-39,518,000
OpCashFlow TTM
—
Assets (Latest)
$23,041,000
Forward EPS
$-2.44

Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $3.42 · call volume: 100 · put volume: 0

Peers — same industry

TickerNameMarket CapLastDaily %
SMNR Semnur Pharmaceuticals, Inc. $46.04M $0.20 —
RFL Rafael Holdings, Inc. $46.95M $0.91 —
NMAD NOMAD POWER SOLUTIONS, INC. $48.30M $3.00 —
MREO Mereo BioPharma Group plc $43.84M $0.27 —
APLM Apollomics Inc. $49.09M $16.84 —

News headlines (Yahoo Finance, 1h cache)

Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application
2026-11-12 17:09 · Yahoo
Clene Inc. (CLNN) Tops Q3 Earnings Estimates
2026-11-04 14:05 · Yahoo
Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights
2026-11-04 13:30 · Yahoo
Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision
2026-10-02 12:02 · Yahoo
Clene to Present at Upcoming Investor Conferences
2026-09-22 12:00 · Yahoo
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
2026-09-21 12:30 · Yahoo
Clene Announces $4 Million Registered Direct Offering
2026-09-15 13:00 · Yahoo
Clene to Present at Upcoming September Investor Conferences
2026-09-03 12:00 · Yahoo
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses
2026-08-19 22:03 · Yahoo
Clene to Present at the Emerging Growth Conference
2026-08-17 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.